Hyun-jung Byun

Goyang, 100715, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Snail Promotes Cancer Cell Proliferation via Its Interaction with the BIRC3.

Snail Promotes Cancer Cell Proliferation via Its Interaction with the BIRC3.

Journal: Biomolecules & therapeutics

Published: May 11, 2022

IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer.

IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer.

Journal: International journal of molecular sciences

Published: September 17, 2020

The anti-tumor activator sMEK1 and paclitaxel additively decrease expression of HIF-1α and VEGF via mTORC1-S6K/4E-BP-dependent signaling pathways.

The anti-tumor activator sMEK1 and paclitaxel additively decrease expression of HIF-1α and VEGF via mTORC1-S6K/4E-BP-dependent signaling pathways.

Journal: Oncotarget

Published: August 26, 2014

Tumor suppressor BLU promotes paclitaxel antitumor activity by inducing apoptosis through the down-regulation of Bcl-2 expression in tumorigenesis.

Tumor suppressor BLU promotes paclitaxel antitumor activity by inducing apoptosis through the down-regulation of Bcl-2 expression in tumorigenesis.

Journal: Biochemical and biophysical research communications

Published: April 16, 2013

BLU enhances the effects of anti-angiogenic activity in combination with gemcitabine-based chemotherapeutic agents.

BLU enhances the effects of anti-angiogenic activity in combination with gemcitabine-based chemotherapeutic agents.

Journal: The international journal of biochemistry & cell biology

Published: February 20, 2013

GABAA receptor-binding protein promotes sensitivity to apoptosis induced by chemotherapeutic agents.

GABAA receptor-binding protein promotes sensitivity to apoptosis induced by chemotherapeutic agents.

Journal: International journal of oncology

Published: January 16, 2013

sMEK1 enhances gemcitabine anti-cancer activity through inhibition of phosphorylation of Akt/mTOR.

sMEK1 enhances gemcitabine anti-cancer activity through inhibition of phosphorylation of Akt/mTOR.

Journal: Apoptosis : an international journal on programmed cell death

Published: August 21, 2012

Anti-angiogenic effects of thioridazine involving the FAK-mTOR pathway.

Anti-angiogenic effects of thioridazine involving the FAK-mTOR pathway.

Journal: Microvascular research

Published: May 16, 2012

Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells.

Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells.

Journal: Apoptosis : an international journal on programmed cell death

Published: March 31, 2012

DAPk1 inhibits NF-κB activation through TNF-α and INF-γ-induced apoptosis.

DAPk1 inhibits NF-κB activation through TNF-α and INF-γ-induced apoptosis.

Journal: Cellular signalling

Published: February 20, 2012

Dickkopf-1 (DKK-1) interrupts FAK/PI3K/mTOR pathway by interaction of carbonic anhydrase IX (CA9) in tumorigenesis.

Dickkopf-1 (DKK-1) interrupts FAK/PI3K/mTOR pathway by interaction of carbonic anhydrase IX (CA9) in tumorigenesis.

Journal: Cellular signalling

Published: January 11, 2012

Tumor suppressor BLU enhances pro-apoptotic activity of sMEK1 through physical interaction.

Tumor suppressor BLU enhances pro-apoptotic activity of sMEK1 through physical interaction.

Journal: Cellular signalling

Published: December 14, 2011

Showing 1-12 of 13

Last Updated: 09/26/2026